Pfizer Sales to Be Hurt in Next 2 Years NEW YORK - Pharmaceutical giant Pfizer Inc. reiterated Tuesday it would meet its 2004 earnings target but said over the next two years it would lose \$14 billion in revenues because of patent expirations.